Today's Issue

Main Topic: What D-mannose and cranberry actually do, what the clinical trials found for each one, why the results diverge, and what the evidence-based approach to UTI prevention actually looks like

Abstract: Urinary tract infections (UTIs) affect approximately 50-60% of women at least once in their lifetime, with 20-24% experiencing recurrence within a year. E. coli causes approximately 80-85% of UTIs and relies on type 1 fimbriae (hair-like appendages) to adhere to mannose residues on the surface of bladder cells. D-mannose, a simple sugar, is proposed to competitively inhibit this adhesion by flooding the bladder with free mannose that E. coli binds to instead of the bladder wall. A 2024 JAMA Internal Medicine randomized controlled trial of 598 women found D-mannose did not significantly reduce UTI recurrence over 6 months compared to placebo. A 2025 updated meta-analysis of 6 RCTs (1,167 participants) found D-mannose reduced UTI risk versus no treatment but showed no significant benefit versus antibiotics. The 2022 Cochrane review found "little to no evidence to support or refute" D-mannose for UTI prevention. In contrast, a 2023 Cochrane systematic review of cranberry products found standardized cranberry extract significantly reduces recurrent UTIs in women, children, and high-risk individuals. Cranberry's active compounds (proanthocyanidins, specifically PAC-A type) prevent both type 1 and P-fimbriae bacterial adhesion. The key variable for cranberry is standardization: products must contain a minimum of 36mg PAC per daily dose to show clinical effect. Cranberry juice is generally insufficient due to low PAC concentration and high sugar content.

I'm 63 With $1.5M. Can I Spend $10K a Month?

You’ve saved $1.5 million. Now comes the real test.

Can it produce $10,000 a month, or will that pace drain your portfolio?

Most retirees do not get a clear answer until it is too late.

The issue is not just how much you have. It is whether your portfolio was built to pay you, not just grow.

That difference can determine whether your money lasts decades or starts breaking down early.

Sequence of returns, taxes on withdrawals, healthcare costs, and whether the 4% rule still applies all play a role.

Fiduciary advisors created a breakdown showing what drives sustainable income and why the same $1.5M can produce very different outcomes.

If you have $1M or more invested, do not guess.

See How Long My Money Lasts

Learn More

1. Why UTIs Keep Coming Back: The Biology 🦠🔬

E. coli causes approximately 80-85% of all UTIs.

It does not just drift into the bladder accidentally. It climbs there, using tiny hair-like appendages called fimbriae that latch onto specific receptor sites on bladder wall cells.

The receptor those fimbriae attach to contains mannose, a simple sugar naturally present on the surface of bladder cells.

This is where both supplements try to intervene.

D-mannose works by flooding the bladder with free mannose, giving the bacteria something to bind to other than your bladder wall.

Cranberry works by changing the structure of the bacterial fimbriae themselves, making them less able to grip onto anything at all.

Same problem. Different solutions. Very different evidence.

2. D-Mannose: The Promising Theory That Hit a Wall 📊❌

The mechanism behind D-mannose is elegant and logical.

Flood the bladder with free mannose. E. coli binds to the free mannose instead of your bladder wall. It gets flushed out with your next urination. No adhesion, no infection.

Earlier small trials supported this. A 2014 study found D-mannose reduced recurrence rates. The supplement industry ran with it.

Then came the 2024 trial.

A randomized controlled trial published in JAMA Internal Medicine in April 2024 found that daily D-mannose supplementation in 598 women for six months did not significantly reduce UTI recurrence.

598 women. Six months. Double-blind. The most rigorous test D-mannose had ever faced. It did not pass.

A 2022 Cochrane review concluded that "there is currently little to no evidence to support or refute the use of D-mannose to prevent or treat UTIs in all populations."

A 2025 meta-analysis of 6 RCTs found D-mannose reduced UTI risk versus doing nothing, but showed no significant benefit versus antibiotics.

3. Cranberry: The One Science Is Actually Backing 🍒✅

Cranberry has been dismissed and confirmed in cycles for decades.

The dismissals came from trials using cranberry juice, which contains too little of the active compound and too much sugar to show a meaningful effect.

The confirmations come from trials using standardized cranberry extract, concentrated to a specific level of the compound that actually does the work.

That compound is proanthocyanidins (PACs), specifically the A-type PACs unique to cranberry.

They work differently from D-mannose. Instead of just competing for the binding site, they physically alter the structure of bacterial fimbriae, making E. coli less able to grip anything at all.

The product label needs to specify PAC content. If it does not, assume it is insufficient.

4. What Your Doctor Never Told You About Both 🏥🔒

UTIs are the second most common infectious disease diagnosis globally.

They are also one of the leading drivers of antibiotic prescriptions, and antibiotic resistance in E. coli is rising in exactly the populations who get UTIs most frequently.

Most doctors do not mention D-mannose or cranberry until a patient asks. Many still dismiss cranberry based on the old juice trials rather than the newer extract data.

The antibiotic reflex for UTIs is clinically understandable. Antibiotics work. They work fast. The problem is that repeated antibiotic courses disrupt the gut and urogenital microbiome, select for resistant strains, and increase the likelihood of future recurrent infections.

For women with recurrent UTIs specifically (defined as two or more per year), the case for incorporating evidence-backed non-antibiotic prevention is stronger than most consultations reflect.

5. What the Evidence-Based Approach Actually Looks Like ✅📋

For cranberry: Use a standardized extract supplement specifying at least 36mg PAC per daily dose. Not cranberry juice. Not a supplement that lists only "cranberry fruit" without PAC content.

For D-mannose: The mechanism is still plausible. The large trial was negative. Some people report benefit despite the trial data. If you choose to try it, 2g per day is the dose used in most positive studies. It is safe, has no significant side effects, and is worth a personal trial if recurrent UTIs are a problem. Just go in with accurate expectations.

What to do during an active infection: Neither supplement is a treatment. Both are prevention tools. An active UTI with symptoms (burning, urgency, frequency, cloudy urine) requires medical evaluation. Delaying antibiotic treatment for an active infection based on supplement use risks the infection ascending to the kidneys, which is a significantly more serious condition.

What else matters: Hydration. Urination after intercourse. Avoiding spermicides (which disrupt the vaginal microbiome and significantly increase UTI risk). Probiotic strains Lactobacillus rhamnosus and Lactobacillus reuteri have emerging evidence for urogenital microbiome support.

Takeaways

• E. coli causes 80-85% of UTIs by using fimbriae to adhere to mannose receptors on bladder cells; D-mannose attempts to block this adhesion by flooding the bladder with free mannose, but a 2024 JAMA Internal Medicine trial of 598 women found it did not significantly reduce UTI recurrence, and a 2022 Cochrane review found little to no evidence supporting its use, making the mechanism plausible but the clinical evidence currently insufficient.

• Cranberry's A-type proanthocyanidins (PACs) physically alter bacterial fimbriae structure, making E. coli less able to adhere to any surface; a 2023 Cochrane meta-analysis confirmed standardized cranberry extract significantly reduces recurrent UTIs in women, children, and high-risk individuals, with the critical threshold being 36mg PAC per daily dose, a level most cranberry juice and many low-quality supplements do not reach.

• Neither supplement is a treatment for an active UTI; both are prevention tools for recurrent infections; the evidence-based approach is standardized cranberry extract (36mg PAC daily, ongoing) with D-mannose as a reasonable personal trial at 2g/day, alongside hydration, post-intercourse urination, avoidance of spermicides, and consideration of Lactobacillus rhamnosus and reuteri for vaginal microbiome support.

The Golf Leaderboard Is a Market

Trade golf's biggest weekend on Kalshi. Take positions on real outcomes — winner, leaderboard, head-to-heads. No house, peer-to-peer, cash out anytime.

Start with $10 here.

_{Trade responsibly.}